Stock Market
Watch
×
Search
Home
Markets
Stock Market Today
SP500
Dow Jones
Nasdaq
NYSE
AMEX
Forex
Movers
PreMarket
Top Movers
After Hours
Watchlists
AI Ports
Crypto
Metals
Metal Prices
Gold Price
Silver Price
Copper Price
Platinum Price
Palladium Price
Learn
PIRS Stock Price Today
Add to Watchlist
Quote
Premarket
Analysts
Insiders
Financials
Earnings
Filings
Profile
Historical
Performance
PIRS Stock Quote and Chart
Track all markets on TradingView
PIRS News
Palvella Therapeutics Completes Enrollment for Pivotal Phase 3 Trial of QTORIN Rapamycin
Palvella Therapeutics Inc. (NASDAQ:PVLA) is one of the best-performing NASDAQ stocks according to an...
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
Enrollment of 51 subjects highlights significant unmet need in this serious, lifelong genetic diseas...
PALVELLA THERAPEUTICS, INC.: Form 4 - Statement of changes in beneficial ownership of securities
PALVELLA THERAPEUTICS, INC.: Form 4 - Statement of changes in beneficial ownership of securities
PALVELLA THERAPEUTICS, INC.: Form 4 - Statement of changes in beneficial ownership of securities
PIRS Financials
Track all markets on TradingView
PIRS Tech Analysis
Track all markets on TradingView
PIRS Profile
Track all markets on TradingView